Bavarian Nordic Logo

Bavarian Nordic

Biotechnology company developing and commercializing vaccines for infectious diseases.

BAVA | CO

Overview

Corporate Details

ISIN(s):
DK0015998017 (+1 more)
LEI:
2138006JCDVYIN6INP51
Country:
Denmark
Address:
PHILIP HEYMANS ALLE 3, 2900 HELLERUP

Description

Bavarian Nordic is a fully integrated biotechnology company specializing in the research, development, manufacturing, and commercialization of life-saving vaccines. The company's portfolio targets infectious diseases, including vaccines for Mpox, rabies, and typhoid. It is a leading global provider of travel vaccines and serves as a key partner for governments and international organizations in addressing public health preparedness needs.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2016-01-05 15:34 Danish 10.0 KB
2016-01-04 15:02 Danish 14.9 KB
2016-01-04 15:02 English 100.0 KB
2015-12-18 07:30 Danish 16.2 KB
2015-12-18 07:30 English 116.1 KB
2015-12-09 12:03 Danish 69.6 KB
2015-12-08 15:08 Danish 14.1 KB
2015-12-08 15:08 English 100.2 KB
2015-11-16 13:17 Danish 3.0 KB
2015-11-16 13:17 English 138.9 KB
2015-11-16 10:31 Danish 11.0 KB
2015-11-16 10:31 English 109.2 KB
2015-11-12 14:56 English 110.1 KB
2015-11-12 14:55 Danish 138.0 KB
2015-11-03 14:00 Danish 12.2 KB

Automate Your Workflow. Get a real-time feed of all Bavarian Nordic filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bavarian Nordic

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bavarian Nordic via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Celemics, Inc. Logo
Develops NGS target enrichment solutions for research and clinical applications.
South Korea
331920
Develops radiopharmaceuticals and radioligand therapies for oncology.
South Korea
308430
CELL BIOTECH CO ., LTD Logo
Develops and manufactures probiotic solutions using patented dual-coating technology.
South Korea
049960
Celldex Therapeutics, Inc. Logo
Develops antibody-based immunotherapies for severe inflammatory and allergic diseases.
United States of America
CLDX
Cellectar Biosciences, Inc. Logo
Clinical-stage biopharma developing targeted cancer treatments via a PDC platform.
United States of America
CLRB
Cellectis Logo
Develops allogeneic, or 'off-the-shelf', CAR T-cell immunotherapies for cancer.
France
ALCLS
Cellid Co., Ltd. Logo
Develops immunotherapeutic vaccines for cancer and infectious diseases.
South Korea
299660
Cellromax Science Co., Ltd. Logo
Researches and develops health foods, derma-cosmetics, and OTC pharmaceuticals.
South Korea
471820
CellSeed Inc. Logo
Develops and commercializes cell sheet engineering for regenerative medicine.
Japan
7776
Celltrion, Inc. Logo
Biopharmaceutical firm developing biosimilars for autoimmune diseases and oncology.
South Korea
068270

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.